Cargando…

Valuation techniques : discounted cash flow, earnings quality, measures of value added, and real options /

Analysis and insights from top thought leaders on a pivotal topic in investing and asset management Valuation is the cornerstone for investment analysis, and a thorough understanding and correct application of valuation methodologies are critical for long-term investing success. Edited by two leadin...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Larrabee, David T.
Otros Autores: Voss, Jason Apollo
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, New Jersey : John Wiley & Sons, Inc., ©2013.
Colección:CFA Institute investment perspectives series.
Temas:
Acceso en línea:Texto completo
Texto completo
Tabla de Contenidos:
  • Foreword
  • Introduction
  • Part I. : Valuation Perspectives: Then and Now
  • 1. : Two Illustrative Approaches to Formula Valuations of Common Stocks
  • Notes
  • 2. : Seeking a Margin of Safety and Valuation
  • Two Basic Investment Goals
  • The Price of Money is Fake
  • The Future is Uncertain
  • Dealing with Macro Risk
  • Owning an Enterprise Preserves Purchasing Power
  • Seek a Margin of Safety
  • Valuation
  • Business Model Erosion
  • Focus on Assets, Not on Residual Equity.
  • ManagementFlexibility to Look Different
  • Conclusion
  • Question and Answer Session
  • Note
  • Part II. : Valuation Methodologies
  • 3. : Company Performance and Measures of Value Added
  • Foreword
  • Introduction
  • How Value Is Created
  • Relating New Performance Methods to Capital-Budgeting Techniques
  • Summary
  • Traditional Measures of Performance
  • Return-on-Investment Ratios
  • Tobin's q
  • Summary
  • Measures of Value Added
  • Economic Profit
  • Market Value Added
  • Reconciling Economic Value Added with Market Value Added
  • Challenges in Applying Value-Added Measures
  • Holt's Cfroi
  • Summary.
  • Comparison of Alternative Performance MeasuresThe Sample
  • The Variables
  • Empirical Results
  • Summary
  • Conclusions
  • Appendix 3. A: The Firm's Cost Of Capital
  • Cost of Debt
  • Cost of Preferred Stock
  • The Cost of Common Equity
  • Weighted-Average Cost of Capital
  • Issues in Calculating a WACC
  • Appendix 3. B: Net Present Value and Internal Rate of Return
  • Notes
  • 4. : The Affordable Dividend Approach to Equity Valuation
  • Affordable Dividends
  • Affordable vs. Conventional dividends
  • Significance of Difference
  • Book Value vs. Economic Value weights
  • Conclusion
  • Notes.
  • 5. : Discounted-Cash-Flow Approach to ValuationThe DCF Formula
  • Estimation of Cash Flows
  • Discount Rate
  • Definition
  • External Factors
  • Internal Factors
  • Components
  • Terminal Value
  • Conclusion
  • Question and Answer Section
  • Note
  • 6. : Equity Securities Analysis Case Study: Merck & Company
  • Recent Annual Reports
  • Strategic Objectives
  • Structural Reorganization
  • Position on Health Care Reform
  • Outlook for the Future
  • Fundamentals of the U.S. Pharmaceutical Industry
  • Pricing and the Demand for Pharmaceuticals
  • Consolidation and Joint Ventures
  • Marketing Trends.
  • International CompetitionThe U.S. Political/Regulatory Environment
  • Tasks to be Completed
  • Appendix 6. A: Merck & Company Financial Data
  • Appendix 6. B: Statistical Data: Pharmaceutical Industry
  • Appendix 6. C: Competitive Strategy Analysis Framework
  • Appendix 6. D: Review of the Dupont Financial Ratio Analysis Method
  • Appendix 6. E: Selected Valuation Methods
  • Single-Stage Constant-Growth DCF Model
  • Multistage DCF Model
  • H-Model
  • Financial Ratios Approaches
  • Guideline Answers: The Merck Case
  • The Current Issues Involved in Marketing Pharmaceuticals.
  • The Competitive Structure of the U.S. Pharmaceutical Industry.